Technical Analysis for NVO - Novo Nordisk A/S
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Flat |
| See historical NVO trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jan 17 | Crossed Above 200 DMA | Bullish | 0.00% |
| Jan 17 | Cup with Handle | Other | 0.00% |
| Jan 16 | Fell Below 200 DMA | Bearish | 1.66% |
| Jan 16 | MACD Bearish Signal Line Cross | Bearish | 1.66% |
| Jan 16 | Cup with Handle | Other | 1.66% |
| Jan 15 | Crossed Above 200 DMA | Bullish | 0.95% |
| Jan 15 | Cup with Handle | Other | 0.95% |
| Jan 15 | Narrow Range Bar | Range Contraction | 0.95% |
| Jan 15 | Gapped Up | Strength | 0.95% |
| Jan 15 | Overbought Stochastic | Strength | 0.95% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2018-11-07
- Sector: Healthcare
- Industry: Pharmaceuticals
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more NVO news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 58.37 |
| 52 Week Low | 41.23 |
| Average Volume | 1,555,452 |
| 200-Day Moving Average | 46.9503 |
| 50-Day Moving Average | 45.7626 |
| 20-Day Moving Average | 46.643 |
| 10-Day Moving Average | 47.765 |
| Average True Range | 0.8584 |
| ADX | 13.65 |
| +DI | 29.919 |
| -DI | 26.4174 |
| Chandelier Exit (Long, 3 ATRs ) | 46.3748 |
| Chandelier Exit (Short, 3 ATRs ) | 46.1752 |
| Upper Bollinger Band | 49.4478 |
| Lower Bollinger Band | 43.8382 |
| Percent B (%b) | 0.68 |
| BandWidth | 12.026671 |
| MACD Line | 0.5809 |
| MACD Signal Line | 0.6131 |
| MACD Histogram | -0.0321 |
| Fundamentals | Value |
|---|---|
| Market Cap | 118.18 Billion |
| Num Shares | 2.48 Billion |
| EPS | 2.49 |
| Price-to-Earnings (P/E) Ratio | 19.14 |
| Price-to-Sales | 6.57 |
| Price-to-Book | 15.49 |
| PEG Ratio | 2.42 |
| Dividend | 0.95 |
| Dividend Yield | 1.99% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 48.77 | ||||
| Resistance 3 (R3) | 48.69 | 48.24 | 48.58 | ||
| Resistance 2 (R2) | 48.24 | 47.95 | 48.28 | 48.52 | |
| Resistance 1 (R1) | 47.94 | 47.78 | 48.09 | 48.02 | 48.46 |
| Pivot Point | 47.49 | 47.49 | 47.57 | 47.53 | 47.49 |
| Support 1 (S1) | 47.20 | 47.21 | 47.35 | 47.28 | 46.84 |
| Support 2 (S2) | 46.75 | 47.03 | 46.79 | 46.78 | |
| Support 3 (S3) | 46.45 | 46.75 | 46.72 | ||
| Support 4 (S4) | 46.53 |
